|
Monday, 6 October 2014, 16:00 HKT/SGT | |
| | | | Source: M+W Group | |
|
|
Stuttgart, Germany and Shanghai, China, Oct 6, 2014 - (ACN Newswire) - M+W Group, one of the world's leading high-tech engineering and construction companies, has been awarded a major order from Merck for its new pharmaceutical facility in China. The site with around 40,000 squaremeters is located in the Nantong Economical Technological Development area in the Greater Shanghai region. M+W Group will be responsible for the engineering design, procurement, construction management and validation services of the factory including production and support buildings.
The new facility is designed to manufacture multiple types of dry forms of Oral Solid Dosage (OSD) in their final packaging for the Chinese market, with focus on Merck's leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders. Production capacity is planned to reach over two billion tablets per year in the first phase, going operational by the end of 2016. The total building area has about 38,000 squaremeters, with the production building (23,000 squaremeters) as well as the warehouse and logistics building (9,000 squarementers) taking up the most space. Both are dedicated to high level cGMP (current Good Manufacturing Practice) activities. Other buildings will house the central utilities, the fire fighting pump station, canteen and offices.
Dr. Olaf Berlien, CEO of M+W Group, about this new order: "We are pleased that this new pharmaceutical facility will not only strengthen Merck's presence in China, but will also contribute to covering China's growing healthcare needs in important areas like diabetes, cardiovascular diseases and thyroid disorders."
About the M+W Group
M+W Group, with headquarters in Stuttgart, Germany, is one of the leading global companies in the field of high-tech engineering, procurement and construction. From concept development to turnkey solutions, the Group manages projects of all sizes for many industries. Founded in 1912, the company is recognized today as a market leader in several segments, such as the semiconductor and photovoltaic industries. In 2013, M+W Group generated an order intake of 3.03 billion euros and revenues of 2.56 billion euros with around 8,500 employees. More information: www.mwgroup.net.
About Merck Group
www.merckgroup.com
Press contact: Michael Gemeinhardt Phone: +49 711 8804-1420 Mail: michael.gemeinhardt@mwgroup.net
Scope: Engineering Design, Procurement, Construction Management and Validation
Topic: Contract Awarded
Source: M+W Group
Sectors: BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
M+W Group |
Mar 15, 2017 21:00 HKT/SGT |
M+W Group receives Chinese Grade A License as a Building Project General Contractor |
Apr 16, 2015 16:20 HKT/SGT |
Mark Garvey appointed new Chief Executive Officer for M+W Group's Asia-Pacific region |
Apr 15, 2015 09:00 HKT/SGT |
Mark Garvey appointed new Chief Executive Officer for M+W Group's Asia-Pacific region |
May 10, 2013 14:00 HKT/SGT |
M+W Group at AchemAsia 2013 with Integrated Solutions for the Biotech, Chemical, Consumer Care, Nutrition and Pharmaceutical Industries |
May 15, 2012 13:00 HKT/SGT |
M+W Group Acquires Engineering Company Specialized in the Power Plant Sector |
Feb 29, 2012 15:00 HKT/SGT |
M+W Group Wins Major Contract for the New Infineon Semiconductor Plant in Malaysia |
Oct 28, 2011 17:57 HKT/SGT |
M+W Group Breaks 7,000-employee Barrier |
Oct 25, 2011 10:00 HKT/SGT |
M+W Group completes an ultra-modern paint manufacturing facility for Jotun in Malaysia |
May 28, 2010 12:00 HKT/SGT |
M+W Group at the AchemaAsia Show in Beijing: Integrated Solutions for Pharmaceutical, Biotech, Chemical, Food & Beverages, Nutritional, Microelectronic and PV Industries |
Dec 18, 2009 08:18 HKT/SGT |
From 1st January 2010 M+W Zander Will Have a New Name and Logo: M+W Zander is to Become M+W Group |
More news >> |
|
|
|
|